UK - Pension funds want drugs giant GlaxoSmithKline to explain why its chief executive's pay package is rising by £2.5m while the firm's share price is falling sharply.
The National Association of Pension Funds’ request follows a letter from the company stating its intention to recommend an increase in Jean-Pierre Garnier’s “long-term incentive grants”. The let...
To continue reading this article...
Join Professional Pensions
Become a Professional Pensions Lite Member today
In just a few clicks you can start your free Professional Pensions Lite membership for 12 months, providing you access to:
- Three complimentary articles per month covering the latest real-time news, analysis and opinion from the industry
- Receive important and breaking news stories via our two daily news alerts
- Hear from industry experts and other forward-thinking leaders
